(Values in U.S. Thousands) | Dec, 2023 | Dec, 2022 | Dec, 2021 | Dec, 2020 | Dec, 2019 |
Sales | 5,900 | 8,260 | 8,250 | 7,380 | 9,270 |
Sales Growth | -28.57% | +0.12% | +11.79% | -20.39% | -42.39% |
Net Income | -6,530 | -4,420 | -2,280 | -2,090 | -3,770 |
Net Income Growth | -47.74% | -93.86% | -9.09% | +44.56% | -18,950.00% |
Neurometrix Inc (NURO)
4.17 x 20 4.65 x 10
Post-market by (Cboe BZX)
4.38 -0.01 (-0.23%) 02/24/25 [NASDAQ]
4.17 x 20 4.65 x 10
Post-market 4.38 unch (unch) 12:58 ET
for Mon, Feb 24th, 2025
Neurometrix is a medical device company establishing a new standard of care through the design, development and sale of proprietary products used to diagnose neuropathies. Neuropathies are diseases of the peripheral nerves and parts of the spine that frequently are caused by or associated with diabetes, low back pain and carpal tunnel syndrome, as well as other clinical disorders.
Fiscal Year End Date: 12/31